Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Azelis launches excipients in UK

27-Jul-2010

Related topics: Ingredients

Azelis Pharma has launched Syral starch-derived oral excipients in the UK.

Introduction of the products expands the portfolio of excipients marketed by Azelis in the UK. Most of the excipients meet European and US pharma monographs.

The new additions include liquid and powder forms of sorbitol and maltitol, maize starch, dextrose monohydrate, maltodextrins, dextrose anhydrous, and glucose syrup.

These excipients can be used in capsules, tablets, suspensions, and syrups. Trevor Bridger, regional business manager for Azelis Pharma, said the new products, combined with its specialty flavours, sweeteners and other oral excipients, position it to serve the UK pharma market.

Copyright - Unless otherwise stated all contents of this web site are © 2012 - William Reed Business Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department copyright@wrbm.com - Full details for the use of materials on this site can be found in the Terms & Conditions

© 2012 - William Reed Business Media SAS - All rights reserved.